Literature DB >> 2567671

Modulation of catecholamine effects during hypoglycaemia in man by urapidil and propranolol.

K G Petersen1, P Katschker, L Kerp.   

Abstract

The hypothesis that in hypoglycaemia adrenoceptor-blocking drugs may enhance those metabolic effects of the catecholamines that remain unblocked has been investigated in 12 volunteers. alpha-Adrenoceptor blockade with urapidil increased the heart rate and the plasma noradrenaline level, and increased the beta-adrenoceptor mediated cellular uptake of potassium and phosphate, and the production of lactate. Posthypoglycaemic glucose intolerance and the counterregulatory responses of hGH and cortisol remained unchanged. Plasma adrenaline, the alpha-adrenoceptor mediated responses of cortisol and hGH, and the diastolic blood pressure were increased by propranolol. Adrenoceptor blocking drugs produce an indirect stimulatory effect by eliciting a reflex increase in sympathetic tone, which is manifested as stimulation of receptors of the type that has not been blocked.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567671     DOI: 10.1007/BF00558294

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  On some physiological actions of ergot.

Authors:  H H Dale
Journal:  J Physiol       Date:  1906-05-31       Impact factor: 5.182

2.  The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia.

Authors:  K J Schlüter; W H Aellig; K G Petersen; H C Rieband; A Wehrli; L Kerp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.

Authors:  P E Cryer; M W Haymond; J V Santiago; S D Shah
Journal:  N Engl J Med       Date:  1976-09-09       Impact factor: 91.245

4.  Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.

Authors:  D A Popp; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

5.  Hypoglycemia following insulin and proinsulin. A comparison.

Authors:  K G Petersen; T Licht; M Storch; P R Pilot; A Alexopoulos; M Lehmann; S Weigel; L Kerp
Journal:  Horm Metab Res       Date:  1986-08       Impact factor: 2.936

6.  Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.

Authors:  G Bolli; P de Feo; P Compagnucci; M G Cartechini; G Angeletti; F Santeusanio; P Brunetti
Journal:  Diabetes       Date:  1982-07       Impact factor: 9.461

7.  Regulation of serum potassium during insulin-induced hypoglycemia.

Authors:  K G Petersen; K J Schlüter; L Kerp
Journal:  Diabetes       Date:  1982-07       Impact factor: 9.461

8.  Adrenergic receptor control mechanism for growth hormone secretion.

Authors:  W G Blackard; S A Heidingsfelder
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

9.  Effects of alpha 1- and alpha 2-adrenoceptor blocking drugs on noradrenaline release rate in anesthetized rabbits.

Authors:  H Majewski; L C Rump; L Hedler; K Starke
Journal:  J Cardiovasc Pharmacol       Date:  1983 Sep-Oct       Impact factor: 3.105

10.  Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.

Authors:  H Imura; Y Kato; M Ikeda; M Morimoto; M Yawata
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.